ESTRO Vision 2030.
"Radiation Oncology. Optimal Health for all, together."
If, by 2035, every cancer patient who needs radiotherapy has access to it, almost one million more lives will be saved every year worldwide.
ESTRO membership 2021
Interview with chair of the 2021 GEC-ESTRO workshop - Brachytherapy Corner
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase III study - Read It
Phase III Randomised Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675) - Read It
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial - Read It
Clinical application of linear accelerator in stereotactic radiotherapy - RTT Corner